Verrica Pharmaceuticals Inc. Long-term Debt, Gross
Verrica Pharmaceuticals Inc. (VRCA) had Long-term Debt, Gross of $3.80 million as of 2022-07-11, per its 10-K filed 2024-02-29.
Discontinued › Notes
us-gaap:DebtInstrumentCarryingAmount · last filed 2024-02-29
- 2022-07-11: Long-term Debt, Gross $3.80M.
- 2022-06-30: Long-term Debt, Gross $40.00M.
- 2022-03-31: Long-term Debt, Gross $40.00M.
- 2021-12-31: Long-term Debt, Gross $40.00M.
| Period end | Long-term Debt, Gross |
|---|---|
| 2022-07-11 | $3.80M 10-K · filed 2024-02-29 |
| 2022-06-30 | $40.00M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $40.00M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $40.00M 10-K · filed 2022-03-02 |
| 2021-09-30 | $40.00M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $40.00M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $40.00M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $35.00M 10-K · filed 2021-03-17 |
| 2020-09-30 | $35.00M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $35.00M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $35.00M 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |